Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.74K Buy
2,000
+1,995
+39,900% +$10.9K ﹤0.01% 6677
2026
Q1
$21 Hold
5
﹤0.01% 7721
2025
Q4
$67 Hold
5
﹤0.01% 7675
2025
Q3
$59 Hold
5
﹤0.01% 7779
2025
Q2
$45 Hold
5
﹤0.01% 7621
2025
Q1
$126 Hold
5
﹤0.01% 7213
2024
Q4
$152 Hold
5
﹤0.01% 7202
2024
Q3
$194 Hold
5
﹤0.01% 7182
2024
Q2
$195 Hold
5
﹤0.01% 7171
2024
Q1
$240 Hold
5
﹤0.01% 6947
2023
Q4
$232 Hold
5
﹤0.01% 7018
2023
Q3
$178 Hold
5
﹤0.01% 7170
2023
Q2
$268 Hold
5
﹤0.01% 7159
2023
Q1
$580 Hold
5
﹤0.01% 7096
2022
Q4
$1K Hold
5
﹤0.01% 6926
2022
Q3
$1K Hold
5
﹤0.01% 7040
2022
Q2
$1K Sell
5
-23
-82% -$5.74K ﹤0.01% 7132
2022
Q1
$11K Hold
28
﹤0.01% 6085
2021
Q4
$11K Buy
28
+4
+17% +$2.31K ﹤0.01% 6191
2021
Q3
$17K Buy
24
+3
+14% +$2.29K ﹤0.01% 5887
2021
Q2
$20K Hold
21
﹤0.01% 5666
2021
Q1
$19K Buy
21
+5
+31% +$5.07K ﹤0.01% 5518
2020
Q4
$12K Buy
16
+7
+78% +$5.99K ﹤0.01% 5442
2020
Q3
$9K Buy
+9
New +$8.73K ﹤0.01% 5337
2020
Q2
Hold
0
6277
2020
Q1
Hold
0
6153

Other funds holding CNSY

Osaic Holdings's CNSY Position: Q2 2026 in Review

Osaic Holdings increased its Cerenome (CNSY) stake by 39,900% in Q2 2026, buying an estimated $10.9K and bringing the position to 2,000 shares worth $8.74K. The position accounts for ﹤0.01% of the portfolio, ranked #6677.

Osaic Holdings first reported a position in CNSY in Q3 2020 and has held it in 24 quarters since. The position peaked at $20K in Q2 2021. 21 funds tracked by Wall St. Rank hold CNSY as of Q2 2026.

  • Osaic Holdings held 2,000 shares of Cerenome worth $8.74K as of Q2 2026.
  • Osaic Holdings bought 1,995 Cerenome shares in Q2 2026, an estimated $10.9K.
  • Cerenome made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #6677 holding.
  • Osaic Holdings first reported a position in Cerenome in Q3 2020 and has held it in 24 quarters since.
  • Osaic Holdings's Cerenome position peaked at $20K in Q2 2021.
  • 21 funds tracked by Wall St. Rank held Cerenome as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.